GC
AVEO

Globeflex Capital’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Globeflex Capital’s Portfolio AVEO Stock Details AVEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-368,520
Closed -$3.03M – 546
2022
Q3 		$3.03M Buy
+368,520
New +$2.83M 0.52% 47
2015
Q3 		– Sell
-29
Closed – – 598
2015
Q2 		$0 Sell
29
-39
-57% -$702 ﹤0.01% 621
2015
Q1 		$1K Sell
68
-25
-27% -$273 ﹤0.01% 498
2014
Q4 		$1K Buy
93
+34
+58% +$311 ﹤0.01% 491
2014
Q3 		$1K Sell
59
-21
-26% -$267 ﹤0.01% 514
2014
Q2 		$1K Buy
+80
New +$1.04K ﹤0.01% 555

Other funds holding AVEO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

Globeflex Capital's AVEO Position: Q4 2022 in Review

Globeflex Capital sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q4 2022, closing a stake of 368,520 shares — an estimated $3.03M sold.

Globeflex Capital first reported a position in AVEO in Q2 2014 and held it in 6 quarters. The position peaked at $3.03M in Q3 2022. 110 funds tracked by Wall St. Rank hold AVEO as of Q4 2022.

  • Globeflex Capital reported no remaining AVEO Pharmaceuticals, Inc. position as of Q4 2022 after selling out during the quarter.
  • Globeflex Capital sold 368,520 AVEO Pharmaceuticals, Inc. shares in Q4 2022, an estimated $3.03M.
  • Globeflex Capital first reported a position in AVEO Pharmaceuticals, Inc. in Q2 2014 and held it in 6 quarters.
  • Globeflex Capital's AVEO Pharmaceuticals, Inc. position peaked at $3.03M in Q3 2022.
  • 110 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q4 2022.

Based on Globeflex Capital's 13F filing for Q4 2022, filed 10 Feb 2023.